RPGLIFE

RPG Life Sciences Share Price

 

 

Invest in RPG Life Sciences with 2.93X leverage

Invest with MTF

Performance

  • Low
  • ₹2,375
  • High
  • ₹2,449
  • 52 Week Low
  • ₹1,835
  • 52 Week High
  • ₹2,729
  • Open Price₹2,449
  • Previous Close₹2,450
  • Volume5,985

Investment Returns

  • Over 1 Month + 6.57%
  • Over 3 Month + 4.63%
  • Over 6 Month + 19.63%
  • Over 1 Year -10.23%

Smart Investing Starts Here Start SIP with RPG Life Sciences for Steady Growth!

Invest Now

RPG Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 18.4
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 3,970
  • P/B Ratio
  • 10.5
  • Average True Range
  • 67.97
  • EPS
  • 67.39
  • Dividend Yield
  • 1
  • MACD Signal
  • 20.5
  • RSI
  • 53.19
  • MFI
  • 84.21

RPG Life Sciences Financials

RPG Life Sciences Technicals

EMA & SMA

Current Price
₹2,400.40
-49.9 (-2.04%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹2,385.87
  • 50 Day
  • ₹2,363.61
  • 100 Day
  • ₹2,346.26
  • 200 Day
  • ₹2,288.07

Resistance and Support

2408.13 Pivot Speed
  • R3 2,515.27
  • R2 2,482.13
  • R1 2,441.27
  • S1 2,367.27
  • S2 2,334.13
  • S3 2,293.27

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

RPG Life Sciences Ltd. is a prominent pharmaceutical company in India, specializing in the development, manufacturing, and marketing of generic formulations, active pharmaceutical ingredients (APIs), and contract research services. The company focuses on quality and innovation across therapeutic segments.

R P G Life Sciences has an operating revenue of Rs. 666.40 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 36% is great, ROE of 34% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 94 which is a GREAT score indicating consistency in earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

RPG Life Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-10-17 Quarterly Results
2025-07-25 Quarterly Results
2025-04-28 Audited Results & Final Dividend
2025-01-24 Quarterly Results
2024-11-07 Quarterly Results
Date Purpose Remarks
2025-06-27 FINAL Rs.20.00 per share(250%)Final Dividend
2025-06-27 SPECIAL Rs.4.00 per share(50%)Special Dividend
2024-06-28 FINAL Rs.16.00 per share(200%)Final Dividend
2023-07-21 FINAL Rs.12.00 per share(150%)Final Dividend
2022-07-15 FINAL Rs.9.60 per share(120%)Final Dividend
View RPG Life Sciences Dividend History Arrow

RPG Life Sciences F&O

RPG Life Sciences Shareholding Pattern

72.95%
3.2%
0.21%
1.11%
0.01%
15.36%
7.16%

About RPG Life Sciences

  • NSE Symbol
  • RPGLIFE
  • BSE Symbol
  • 532983
  • Managing Director
  • Mr. Ashok Nair
  • ISIN
  • INE105J01010

Similar Stocks to RPG Life Sciences

RPG Life Sciences FAQs

RPG Life Sciences share price is ₹2,400 As on 08 November, 2025 | 06:35

The Market Cap of RPG Life Sciences is ₹3970 Cr As on 08 November, 2025 | 06:35

The P/E ratio of RPG Life Sciences is 18.4 As on 08 November, 2025 | 06:35

The PB ratio of RPG Life Sciences is 10.5 As on 08 November, 2025 | 06:35

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23